event,time
46 years old , 0
    African American , 0
    man , 0
    uncontrolled diabetes mellitus , 0
    hypertension , 0
    chronic kidney disease , 0
    polysubstance abuse , 0
    alcohol abuse , 0
    tobacco abuse , 0
    marijuana abuse , 0
    cocaine abuse , 0
    confusion , 0
    difficulty speaking , 0
    temperature 37.6°C (99.7°F) , 0
    blood pressure 154/93 mm Hg , 0
    oriented to self , 0
    expressive (Broca’s) aphasia , 0
    non-fluent speech , 0
    impaired naming , 0
    impaired repetition , 0
    able to follow two-step commands , 0
    good comprehension , 0
    dysarthria , 0
    right-sided hemiparesis , 0
    leukocytosis 12.86 × 10³/μL , 0
    computer tomography left thalamic mass 3.1 cm , 0
    5 mm rightward midline shift , 0
    magnetic resonance imaging confirmed , 0
    admitted to neurological intensive care unit , 0
    empiric intravenous vancomycin , 0
    empiric intravenous meropenem , 0
    stereotactic aspiration , 0
    purulent material , 0
    Gram positive cocci in chains , 0
    Streptococcus anginosus culture , 0
    negative blood cultures , 0
    transthoracic echocardiogram negative for valvular vegetations , 0
    computer tomography sigmoid colitis , 0
    deferred endoscopic evaluation , 0
    antibiotic switched to ceftriaxone , 0
    left against medical advice , 360
    neurosurgery outpatient wound assessment , 720
    persistence of hemiparesis , 720
    no documentation regarding aphasia , 720
    subcortical aphasia , 0
    thalamic brain abscess , 0
    area of sigmoid colitis , 0
    encephalopathy , 0
    contralateral hemiparesis , 0
    expressive aphasia , 0
    deep-seated abscess , 0
    vasogenic edema , 0
    intravenous antimicrobials , 0
    resolution of abscesses , 0
    intraventricular rupture risk , 0
    permanent neurological damage risk , 0
    mortality risk , 0
    morbidity risk , 0
    follow up imaging , 720
    therapeutic end point , 720
    resolution of disease , 720
    46 years old , 0  
African American , 0  
man , 0  
uncontrolled diabetes mellitus , 0  
hypertension ,5 0  
chronic kidney disease , 0  
polysubstance abuse , 0  
alcohol abuse , 0  
tobacco abuse , 0  
marijuana abuse , 0  
cocaine abuse , 0  
confusion , 0  
difficulty speaking , 0  
temperature 37.6°C (99.7°F) , 0  
blood pressure 154/93 mm Hg , 0  
oriented to self , 0  
expressive (Broca’s) aphasia , 0  
non-fluent speech , 0  
impaired naming , 0  
impaired repetition , 0  
able to follow two-step commands , 0  
good comprehension , 0  
dysarthria , 0  
right-sided hemiparesis , 0  
leukocytosis 12.86 × 10³/μL , 0  
computer tomography left thalamic mass 3.1 cm , 0  
5 mm rightward midline shift , 0  
magnetic resonance imaging confirmed , 0  
admitted to neurological intensive care unit , 0  
empiric intravenous vancomycin , 0  
empiric intravenous meropenem , 0  
stereotactic aspiration , 0  
purulent material , 0  
Gram positive cocci in chains , 0  
Streptococcus anginosus culture , 0  
negative blood cultures , 0  
transthoracic echocardiogram negative for valvular vegetations , 0  
computer tomography sigmoid colitis , 0  
deferred endoscopic evaluation , 0  
antibiotic switched to ceftriaxone , 0  
left against medical advice , 360  
neurosurgery outpatient wound assessment , 720  
persistence of hemiparesis , 720  
no documentation regarding aphasia , 720  
subcortical aphasia , 0  
thalamic brain abscess , 0  
area of sigmoid colitis , 0  
encephalopathy , 0  
contralateral hemiparesis , 0  
expressive aphasia , 0  
deep-seated abscess , 0  
vasogenic edema , 0  
intravenous antimicrobials , 0  
resolution of abscesses , 0  
intraventricular rupture risk , 0  
permanent neurological damage risk , 0  
mortality risk , 0  
morbidity risk , 0  
follow up imaging , 720  
therapeutic end point , 720  
resolution of disease , 720
